IL15 and neoplasm: However, similar to TRAMP-C1 tumors, only the combination treatment with cyto-IL-15 and ADU led to complete tumor regression (97% volume reduction), had the greatest impact on survival (99 days, p < 0.0001) and cured 7 out of 12 mice (58%) with TRAMP-C2 tumors.